Condition: COVID-19

This is a Phase 3 randomized double-blind placebo controlled study Assessing the Efficacy and Safety of Anti-Spike SARS-CoV-2 Monoclonal Antibodies in Preventing SARS-Cov-2 Infection in Household Contacts of Individuals Infected with SARS-CoV-2

Location(s): Jacksonville (Headquarters)

Condition: COVID-19